Inventor · disambiguated record
William Scott
Also filed as: SCOTT WILLIAM · SCOTT WILLIAM J · SCOTT WILLIAM JOHNSTON
44 granted patents·42 pending applications·955 citations·filing 1997–2016
98Inventor score
Top patents by PatentIndex Score
86 records- 0197US8071616B2Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitorsDUMAS JACQUES·Filed 2010·Granted Dec 6, 2011·48 cites·19 claims
- 0297US7678811B2Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 16, 2010·57 cites·17 claims
- 0397US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0496US7897623B2ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 1, 2011·35 cites·8 claims
- 0596US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0696US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0796US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0894US8841330B2Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2012·Granted Sep 23, 2014·12 cites·14 claims
- 0994US7838541B2Aryl ureas with angiogenesis inhibiting activityBAYER HEALTHCARE LLC·Filed 2003·Granted Nov 23, 2010·55 cites·5 claims
- 1094US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 1193US8618141B2Aryl ureas with angiogenesis inhibiting activityDUMAS JACQUES·Filed 2012·Granted Dec 31, 2013·20 cites·11 claims
- 1292US8242147B2Aryl ureas with angiogenisis inhibiting activityDUMAS JACQUES·Filed 2010·Granted Aug 14, 2012·17 cites·8 claims
- 1392US8124630B2ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2001·Granted Feb 28, 2012·27 cites·16 claims
- 1491US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1588US6344476B1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 1998·Granted Feb 5, 2002·82 cites·18 claims
- 1687US8466283B2Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisHENTEMANN MARTIN·Filed 2007·Granted Jun 18, 2013·19 cites·47 claims
- 1787US6849638B24-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditionsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Feb 1, 2005·36 cites·12 claims
- 1886USRE46856ESubstituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2007·Granted May 22, 2018·9 cites·57 claims
- 1986US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 2086US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 2185US7557129B2Cyanopyridine derivatives useful in the treatment of cancer and other disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 7, 2009·18 cites·18 claims
- 2284US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 2384US6911443B2Imidazopyrimidine derivatives and triazolopyrimidine derivativesBAYER AG·Filed 2001·Granted Jun 28, 2005·32 cites·7 claims
- 2483US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 2580US7928227B22-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Apr 19, 2011·10 cites·28 claims
- 2679US8859572B2Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesisHENTEMANN MARTIN F·Filed 2009·Granted Oct 14, 2014·9 cites·16 claims
- 2778US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 2874US9181188B2Aryl ureas as kinase inhibitorsDUMAS JACQUES·Filed 2012·Granted Nov 10, 2015·3 cites·28 claims
- 2973US8975265B2Substituted imidazo[1,2-a]pyrimidines and —pyridinesINCE STUART·Filed 2011·Granted Mar 10, 2015·3 cites·10 claims
- 3073US8110587B2Aryl ureas as kinase inhibitorsDUMAS JACQUES·Filed 2003·Granted Feb 7, 2012·8 cites·39 claims
- 3172US9370517B2Substituted pyrazolopyrimidines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Jun 21, 2016·2 cites·8 claims
- 3270US8895549B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Nov 25, 2014·2 cites·15 claims
- 3369US8796250B2Diaryl ureas for diseases mediated by PDGFRWILHELM SCOTT·Filed 2004·Granted Aug 5, 2014·5 cites·55 claims
- 3467US9206185B2Imidazopyridazines as Akt kinase inhibitorsBärfacker Lars·Filed 2012·Granted Dec 8, 2015·2 cites·39 claims
- 3566US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 3666US2010075971A1Substituted pyridine derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2009·Application pending·0 cites
- 3763US2008153823A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 3861US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 3961US2009118268A1OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORSRIEDL BERND·Filed 2008·Application pending·0 cites
- 4061US2008227828A1Aryl Ureas With Angiogenisis Inhibiting ActivityDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 4160US2010160371A1Inhibition of p38 kinase activity by aryl ureasRANGES GERALD·Filed 2009·Application pending·0 cites
- 4259US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 4359US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 4458US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 4557US10653684B2Aryl ureas with angiogenisis inhibiting activityBAYER HEALTHCARE LLC·Filed 2014·Granted May 19, 2020·0 cites·8 claims
- 4657US2014329866A1Omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2014·Application pending·0 cites
- 4757US2001027202A1Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4855US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 4953US9902727B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2014·Granted Feb 27, 2018·0 cites·15 claims
- 5053US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William Scott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →